Q4 2023 Theriva Biologics Inc Earnings Call

25d ago, source: Yahoo Finance

Steven A. Shallcross; CEO, CFO, Treasurer, Corporate Secretary & Director; Theriva Biologics, Inc. Operator And greetings, and welcome to the Theriva Biologics full year 2023 investor conference call.

Theriva Biologics Inc TOVX

5d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers

3d ago, source: Benzinga.com

Theriva™ Biologics TOVX, the clinical-stage immuno-oncology company developing therapies for difficult-to-treat cancers, hit several milestones during 2023, potentially positioning it for a ...

Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results

25d ago, source: Business Insider

About Theriva™ Biologics, Inc. Theriva™ Biologics (NYSE American: TOVX), is a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas ...

Buy Recommendation for Theriva Biologics Backed by Promising Oncolytic Adenovirus Platform and Clinical Trial Advancements

23d ago, source: Business Insider

Begin your TipRanks Premium journey today. Theriva Biologics (TOVX) Company Description: Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to ...

Theriva Biologics, Inc.: Theriva Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting

11d ago, source:

Theriva Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in ...

Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript

24d ago, source: InvestingChannel on MSN

Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript March 25, 2024 Theriva Biologics, Inc. beats earnings ...

Theriva Biologics Inc TOVX

26d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Theriva Biologics, Inc. (TOVX) Q4 2023 Earnings Call Transcript

25d ago, source: Seeking Alpha

Greetings, and welcome to the Theriva Biologics Full-Year 2023 Investor Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this conference is being recorded.

Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript

24d ago, source: Insider Monkey

Theriva Biologics, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41. Theriva Biologics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the ...

Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript

24d ago, source:

Q4 2023 Earnings Call Transcript March 25, 2024 Theriva Biologics, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41. Theriva Biologics, Inc. isn’t one of the 30 most ...